Research Topics
| V PerkovicSummaryAffiliation: The George Institute for International Health Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS studyVlado Perkovic
George Institute for International Health, PO Box M201, Sydney, Australia, 2050
J Am Soc Nephrol 18:2766-72. 2007..In conclusion, kidney function should be considered when determining the need for blood pressure lowering therapy in patients with cerebrovascular disease...
Global randomized trials: the promise of India and ChinaVlado Perkovic
The George Institute for Global Health, PO Box M201, Missenden Road, Sydney 2050, Australia
J Bone Joint Surg Am 94:92-6. 2012..Challenges in both countries are substantial but are able to be managed with appropriate planning...- High prevalence of chronic kidney disease in ThailandV Perkovic
George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia
Kidney Int 73:473-9. 2008..This high prevalence of chronic kidney disease in Thailand has obvious implications for the health of its citizens and for the allocation of health-care resources... - Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trialsFiona Turnbull
Blood Pressure Lowering Treatment Trialists Collaboration, The George Institute for International Health, University of Sydney, Sydney, NSW, Australia
Eur Heart J 29:2669-80. 2008..The aims of these overview analyses were to quantify the effects of blood pressure-lowering treatment in each sex and to determine if there are important differences in the proportional benefits of treatment between men and women... 
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trialsF Turnbull
George Institute for International Health, University of Sydney, PO Box M201, Sydney, NSW 2050, Australia
BMJ 336:1121-3. 2008..To quantify the relative risk reductions achieved with different regimens to lower blood pressure in younger and older adults...- Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific regionConall M O'Seaghdha
George Institute for International Health, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, New South Wales 2050, Australia
Hypertension 54:509-15. 2009..10). The results were similar for cohorts in Asia and Australia. These results suggest that primary prevention strategies for renal disease should focus on individuals with elevated blood pressure, diabetes mellitus, and dyslipidemia... - Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trialT Ninomiya
George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia
Kidney Int 73:963-70. 2008..We found that perindopril-based BP lowering effectively prevented recurrent stroke in people with CKD, across a wide range of BP levels, without evidence of an increased risk of stroke in people with low BP levels... - Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsGiovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
BMJ 336:645-51. 2008..To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations)... - Socioeconomic disadvantage and kidney disease in the United States, Australia, and ThailandSarah L White
George Institute, Sydney, NSW, Australia
Am J Public Health 98:1306-13. 2008..We sought to determine whether an elevated burden of chronic kidney disease is found among disadvantaged groups living in the United States, Australia, and Thailand... - ADVANCE: lessons from the run-in phase of a large study in type 2 diabetesVlado Perkovic
The George Institute for International Health, The University of Sydney, NSW, Australia
Blood Press 15:340-6. 2006..Good tolerability and safety of the study drug was confirmed during the active run-in phase of the ADVANCE study... - The CARI guidelines. Dialysis adequacy (HD) guidelinesPeter Kerr
Nephrology (Carlton) 10:S61-80. 2005 - The burden of blood pressure-related disease: a neglected priority for global healthVlado Perkovic
George Institute for International Health, University of Sydney, Royal Prince Alfred Hospital, NSW, Australia
Hypertension 50:991-7. 2007 - New insights from ADVANCEJohn Chalmers
The George Institute for International Health, University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
J Hypertens Suppl 25:S23-30. 2007..5% or less reduces these two outcomes compared with standard guidelines therapy; and finally whether the separate benefits of these two treatment regimens are additive... - ADVANCE: breaking new ground in type 2 diabetesJohn Chalmers
The George Institute for International Health, The University of Sydney and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
J Hypertens Suppl 24:S22-8. 2006..Post-randomization study treatments have been well tolerated, and the completion of follow-up is scheduled in 2007... - Accelerated progression of calcific aortic stenosis in dialysis patientsVlado Perkovic
Department of Nephrology, Royal Melbourne Hospital, Parkville, Vic, Australia
Nephron Clin Pract 94:c40-5. 2003..Little data exist on the rate at which aortic stenosis progresses in this patient group...